Tonic TCR Signaling Inversely Regulates the Basal Metabolism of CD4 by Milam, Ashley A Viehmann et al.
The Jackson Laboratory 
The Mouseion at the JAXlibrary 
Faculty Research 2020 Faculty Research 
8-7-2020 
Tonic TCR Signaling Inversely Regulates the Basal Metabolism of 
CD4 
Ashley A Viehmann Milam 
Juliet M Bartleson 
Michael D Buck 
Chih-Hao Chang 
Alexey Sergushichev 
See next page for additional authors 
Follow this and additional works at: https://mouseion.jax.org/stfb2020 
 Part of the Life Sciences Commons, and the Medicine and Health Sciences Commons 
Authors 
Ashley A Viehmann Milam, Juliet M Bartleson, Michael D Buck, Chih-Hao Chang, Alexey Sergushichev, 
David L Donermeyer, Wing Y Lam, Erika L Pearce, Maxim N Artyomov, and Paul M Allen 
 T Cells+Metabolism of CD4
Tonic TCR Signaling Inversely Regulates the Basal
M. Allen
PaulSergushichev, David L. Donermeyer, Wing Y. Lam, Erika L. Pearce, Maxim N. Artyomov and 
Ashley A. Viehmann Milam, Juliet M. Bartleson, Michael D. Buck, Chih-Hao Chang, Alexey
http://www.immunohorizons.org/content/4/8/485
https://doi.org/10.4049/immunohorizons.2000055doi: 
2020, 4 (8) 485-497ImmunoHorizons 
This information is current as of August 10, 2020.
References
http://www.immunohorizons.org/content/4/8/485.full#ref-list-1
, 17 of which you can access for free at: cites 50 articlesThis article 
Email Alerts
http://www.immunohorizons.org/alerts
Receive free email-alerts when new articles cite this article. Sign up at: 
ISSN 2573-7732.
All rights reserved.
1451 Rockville Pike, Suite 650, Rockville, MD 20852
The American Association of Immunologists, Inc.,
 is an open access journal published byImmunoHorizons
























Tonic TCR Signaling Inversely Regulates the Basal Metabolism
of CD4+ T Cells
Ashley A. Viehmann Milam,*,1 Juliet M. Bartleson,*,1 Michael D. Buck,†,‡ Chih-Hao Chang,§ Alexey Sergushichev,{
David L. Donermeyer,* Wing Y. Lam,k Erika L. Pearce,† Maxim N. Artyomov,* and Paul M. Allen*
*Division of Immunobiology, Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110; †Max
Planck Institute of Immunobiology and Epigenetics, Freiburg 79108, Germany; ‡The Francis Crick Institute, London NW1 1AT, United Kingdom;
§The Jackson Laboratory, Bar Harbor, ME 04609; {ITMO University, St. Petersburg, Russia 197101; and kAmgen Research, Amgen, Inc., South San
Francisco, CA 94080
ABSTRACT
The contribution of self-peptide–MHC signaling in CD4+ T cells to metabolic programming has not been definitively established. In
this study, we employed LLO118 and LLO56, two TCRtg CD4+ T cells that recognize the same Listeria epitope. We previously have
shown that LLO56 T cells are highly self-reactive and respond poorly in a primary infection, whereas LLO118 cells, which are less self-
reactive, respond well during primary infection. We performed metabolic profiling and found that naive LLO118 had a dramatically
higher basal respiration rate, a higher maximal respiration rate, and a higher glycolytic rate relative to LLO56. The LLO118 cells also
exhibited a greater uptake of 2-NBD–glucose, in vitro and in vivo. We extended the correlation of low self-reactivity (CD5lo) with high
basal metabolism using two other CD4+ TCRtg cells with known differences in self-reactivity, AND and Marilyn. We hypothesized that
the decreased metabolism resulting from a strong interaction with self was mediated through TCR signaling. We then used an
inducible knock-in mouse expressing the Scn5a voltage-gated sodium channel. This channel, when expressed in peripheral T cells,
enhanced basal TCR-mediated signaling, resulting in decreased respiration and glycolysis, supporting our hypothesis. Genes and
metabolites analysis of LLO118 and LLO56 T cells revealed significant differences in their metabolic pathways, including the glycerol
phosphate shuttle. Inhibition of this pathway reverts the metabolic state of the LLO118 cells to be more LLO56 like. Overall, these
studies highlight the critical relationship between peripheral TCR–self-pMHC interaction, metabolism, and the immune response to
infection. ImmunoHorizons, 2020, 4: 485–497.
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resting and activated cells. These studies established that naive
T cells mainly use oxidative phosphorylation (OXPHOS) to
generate the relatively low bioenergetic needs required by their
quiescent state, whereas activated T cells shift their metabolism
from OXPHOS to aerobic glycolysis to support the anabolic
reactions demanded by clonal expansion and effector differenti-
ation (1, 2).However,metabolic networks influenceT cell function
beyond simply meeting the energy demands of the T cell. A
multitudeof signalingpathways essential for variousTcell functions
are closely interconnected with metabolic programming, either
throughsharedsignalingcomponentsordirectly throughmetabolite
regulation(3). In the lastdecade,complexroles fordistinctmetabolic
programming in nearly every facet of the T cell response to Ag have
been further elucidated, encompassing expansion, differentiation,
effector function, and memory cell formation and maintenance (3).
Conversely, although there has been some work interrogating the
metabolic intricacies of naive, quiescent T cells, this remains a
relatively underappreciated area of T cell biology.
The dampening of metabolic activity in quiescent T cells is an
active process (4). Studies have unveiled a critical role formTOR1
inhibitors (i.e., TSC1, PTEN, and LKB1) in the enforcement of a
quiescent program in naive, peripheral T cells. These molecules
havebeen shown tohavedistinct effects on the regulationofT cell
homeostasis; interestingly, their deletion also uniquely modifies
how T cells respond to stimulation (5–7). This highlights the
possibility that metabolic networks may prime naive T cells to
tune their eventual response toAg, leadingus toquestionwhether
there is metabolic heterogeneity within the naive CD4+ T cell
population.
Activation of CD4+ T cells involves the integration of multiple
variables: TCR signaling, costimulation, and cytokine instruction.
All three of these activating components have been shown to affect
themetabolism of CD4+ T cells. In a naive state, cytokine signaling
and TCR signaling, through tonic self-pMHC interactions, also
occur. IL-7R signaling has been previously shown to affect naive
T cell metabolism, but this was considered in an all-or-none
manner in which no IL-7R signaling lead to the death of naive
T cells because of an inability to meet their quiescent bioenergetic
needs (8); therefore, we wanted to determine whether subtle
differences in tonic TCR signaling could generate a metabolically
heterogenous pool of naive CD4+ T cells.
Peripheral TCR–self-pMHC interactions are distinct from
thymic–self-pMHC interactions, as they do not induce the same
signals required for positive selection. Instead, peripheral tonic
TCR signaling involves low-level stimulation that does not
propagate canonical activation pathways, but rather generates
nuanced effects on the activation state of the T cell and gene
expression levels (9, 10). There is a wide range of tonic signaling
strengths in the naive polyclonal T cell population, as determined
by Nur77 (11, 12) and CD5 (13) expression. This implies that
interactionsof an individualTCRwith a specific self-pMHCligand
controls the level of tonic signaling on a cellular basis.
Several studies involving blockade of TCR–self-pMHC inter-
actions, either with anti–MHC class II Abs or genetic deletion of
MHCclass II onAPCs, have revealed the role tonic signaling plays
in survival, homeostatic expansion, and Ag reactivity of CD4+
Tcells (14–24). Interestingly, tonic signalinghas alsobeen linked to
metabolic activity inmemoryCD4+Tcells.Whendeprived of class
II interactions, memory T cells responded poorly and had
indications of overall diminished metabolic activity relative to
T cells that maintained TCR–self-pMHC interactions (14, 16, 19).
The two primary indicators of tonic TCR signaling strength, CD5
and Nur77, have also been shown to act as regulators of T cell
metabolism postactivation to alter Teff function in vivo (25–27).
To explore whether tonic TCR signaling could influence a
naive T cell’s metabolic programming, we employed LLO56 and
LLO118, two TCRtg CD4+ T cells that recognize the same Listeria
monocytogenes epitope with the same affinity, and which have
beenpreviously characterizedbyour laboratory (22,28, 29). In this
study, we show that naive LLO118 cells, which have low-tonic
signaling, exhibit heightened basal metabolic activity when
compared with their high-tonic signaling counterparts, LLO56.
Specifically, metabolic profiling of the cells revealed that naive
LLO118 had a higher basal respiration rate, maximal respiration
rate, and spare respiratory capacity (SRC) relative to LLO56.
LLO118 cells also had a higher glycolytic rate and took up more
2-NBD–glucose thanLLO56. Furthermore, the emergence of these
differences in LLO TCRtg metabolism coincided with the onset of
positive selection in the developing thymocytes, underlining the
dependence of naivemetabolic programming on TCR–self-pMHC
interactions.
Therefore, we hypothesized there was an inverse relationship
between the strengthof tonic signalingandbasalmetabolicactivity
innaiveCD4+T cells,whichwasmediated throughTCR signaling.
We first confirmed that the metabolic phenotype observed in our
LLO TCRtg cells extended to other high and low-tonic signaling
CD4+ T cells by interrogating the basal metabolism of another set
of TCRtg T cells, as well as assessing glucose uptake in polyclonal
CD4+ T cells. We then tested our hypothesis by using a Scn5a/
CD4-cre mouse line, which we have previously demonstrated to
have polyclonal CD4+ T cells with more sensitive TCR proximal
signaling in response to peripheral self-pMHC(28).Themetabolic
properties of Scn5a-expressing naive CD4+ T cells were assessed,
and we found that the increased sensitivity to self resulted in
decreased basal and maximal respiration rates, supporting our
hypothesis. Collectively, these data establish a direct link between
tonic TCR signaling and basal metabolic activity in CD4+ T cells.
MATERIALS AND METHODS
Mice
The LLO56 and LLO118 TCR–transgenic lines, specific for
listeriolysin O (190–205) (LLO190–205/I-A
b), have been previously
described (22, 28, 29). These mice were maintained on a Rag1-
knockout backgroundwith homozygous congenicmarker expres-
sion (LLO118-Ly5.1; LLO56-Thy1.1). The H-Y–specific Marilyn
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FIGURE 1. Naive LLO CD4+ T cells with low-tonic signaling exhibit a higher metabolism than those with high-tonic signaling.
(A) Enriched CD4+ T cells from spleens of LLO56 and LLO118 TCRtg mice were analyzed using a standard Seahorse protocol, with stepwise
injections of oligomycin, FCCP, and rotenone plus antimycin A. A total of 2 to 3 3 105 cells per well were used, with the cell counts always matched
between mice on individual runs, and a minimum of three wells per mouse were plated. The OCR, a readout of cellular respiration, was measured,
and a representative OCR curve is shown. (B) Basal OCR, the first OCR data point collected, was plotted for LLO56 and LLO118 pairs from individual
Seahorse runs (n = 10). Plot points represent averages of a minimum of three wells; p = 0.0009 by a paired t test. (C) Maximal OCR, (Continued)
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TCR–transgenic line was acquired from National Institute of
Allergy and Infectious Diseases/Taconic, and the AND TCR–
transgenic line (MCC-I-Ek–specific) and B6 mice were acquired
fromThe Jackson Laboratory. Derivation of the polyclonal Scn5a-
transgenic mouse (and its subsequent crossing to a CD4-Cre line)
has also been previously described (28). All mice were bred
and housed in a specific pathogen-free facility at Washington
University, according to guidelines established by theWashington
University Division of Comparative Medicine.
Seahorse analysis
Oxygen consumption rate (OCR) and extracellular acidification
rate (ECAR) were measured using a 96-well XF extracellular flux
analyzer (Seahorse Bioscience) and Extracellular Flux Assay Kit
(XFe96; Agilent Seahorse). Assay setup has been previously de-
scribed (30–33). Briefly, cells were plated in XF media supple-
mented with glucose (25 mM), L-glutamine (2 mM), and sodium
pyruvate (1 mM). Measurements were taken at basal state, and
after the stepwise additionof oligomycin (1mM), carbonyl cyanide-
4-(trifluoromethoxy) phenylhydrazone (FCCP) (1.5 mM), and
rotenone (100 mM) plus antimycin A (1 mM). The mGPD2 specific
inhibitor, iGP-1 (#5.30655.0001; Calbiochem/EMDMillipore) was
dissolved in DMSO and added to the extracellular flux analyses at
either 2.5 or 5.0 mM final concentration.
2-NBD–glucose uptake
To measure in vitro 2-NBD–glucose uptake in T cells, RBC lysis
was performed on naive splenocytes. TCR-transgenic cells were
further negatively bead enriched for CD4+ T cells (Mouse CD4+
T Cell Kit; Miltenyi Biotec), whereas polyclonal cells were not
enriched.A total of 106CD4+Tcells orpolyclonal splenocyteswere
then plated in duplicate in media (RPMI 1640 with 10% FBS and
Life Technologies Glutamax) supplemented with 50 mg/ml 2-(N-(7-
nitrobenz-2-oxa-1,3-diazol-4-yl)amino)-2-deoxyglucose (2-NBDG)
(Cayman Chemical), for 20 min at 37°C. Cells were then washed
twice in PBS and stained for FACS as described above. Only
CD4+TCRb+T cellswere included in analysis. For in vivo uptake,
2-NBD–glucosewaspreparedat200mg/ml inPBSand injected i.p.
at a dose of 1000mg/kg. Themicewere sacrificed after 15min, the
lymphoid organs harvested and analyzed as described above.
Flow cytometry
All samples were analyzed on BD FACSCanto II or BD
LSRFortessa cytometers, and data were analyzed using FlowJo
software (FlowJo). The following Abs/clones were used for cell
analysis: CD3e (clone 145-2C11, FITC; BioLegend; clone 145-2C11,
allophycocyanin; BioLegend), CD4 (clone RM4.5, FITC; Bio-
Legend; clone RM4.5, eFluor 450; eBioscience; clone RM4.5,
PerCP-Cy5.5; eBioscience), CD5 (clone 53-7.3, FITC; BD Biosci-
ences), CD8a (clone 53-6.7, allophycocyanin; BD Biosciences),
CD45.1/Ly5.1 (cloneA20, eFluor 450; eBioscience),CD90.1/Thy1.1
(clone OX-7, PE; BioLegend), and TCRb (clone H57-597, PerCP-
Cy5.5; BioLegend; clone H57-597, FITC; BD Biosciences).
Transcriptional profiling and genes and
metabolites analysis
Transcriptional profiling ofnaive andD7 in vivo–activatedLLO118
and LLO56 was performed using Affymetrix microarrays (Mouse
Gene ST 1.0; Affymetrix) using standard Affymetric protocols.
Naive LLO118 andLLO56Tcellswere purified from the spleens of
individual mice (n = 4) from each of the TCRtg lines using a
Miltenyi CD4+ Isolation Selection Kit (no. 130-104-454) following
themanufacturer’s instructions.For theD7 invivo–activatedTcell
isolation, 104of eitherLLO118orLLO56Tcellswere injected intoa
wild-type C57BL/6J mouse on day-1. On D0, they were infected
with L. monocytogenes and the spleens from individual mice
(LLO118 n = 4; LLO56 n = 3) were harvested on D7. The T cells
were purified by FACS on a BD FACSAria by sorting on CD4+ and
the appropriate congenic marker (Thy1.1 for LLO118 and Ly5.1 for
LLO56). A dump gate of CD8, CD11b, CD11c, CD19, NK1.1, and
MHC class II was used. RNA was purified from 1.5 to 2 3 106
T cells using an RNeasy Mini Kit (no. 74104; Qiagen), the cDNA
the first OCR data point collected after the injection of FCCP, was plotted from pairs from individual Seahorse runs (n = 10). Plot points represent
averages of a minimum of three wells; p = 0.0004 by a paired t test. (D) SRC was plotted from pairs from individual Seahorse runs (n = 10). SRC was
calculated by subtracting the basal OCR from the maximal OCR; p = 0.0176 by a paired t test. (E) Enriched CD4+ T cells from spleens of LLO56 and
LLO118 TCRtg mice were run using a standard Seahorse protocol, as described in (A). The ECAR, a readout of cellular glycolysis, was measured, and
a representative ECAR curve is shown. (F) Basal ECAR, the first ECAR data point collected, was plotted for LLO56 and LLO118 pairs from individual
Seahorse runs (n = 10). Plot points represent averages of a minimum of three wells; p = 0.0176 by a paired t test. (G) Maximal ECAR, the first ECAR
data point collected after the injection of FCCP, was plotted for LLO56 and LLO118 pairs from individual Seahorse runs (n = 10). Plot points represent
averages of a minimum of three wells; p = 0.0012 by a paired t test. (H) To determine the relative reliance of a CD4+ T cell population on cellular
respiration versus cellular glycolysis, the ratio of OCR/ECAR was calculated by dividing the maximal OCR by the maximal ECAR for each pair of
LLO56 and LLO118; p = 0.5313 by a paired t test. (I) Basal OCR of LLO56 and LLO118 T cells on D7 after in vivo activation by L. monocytogenes
infection as described in (B). The values represent the average of a minimum of three individual wells from individual mice from two independent
experiments; p = 0.0048 by an unpaired t test. (J) Maximal OCR of LLO56 and LLO118 T cells on D7 after in vivo activation by Listeria infection as
described in (C). The values represent the average of a minimum of three individual wells from individual mice from two independent experiments;
p = 0.0266 by an unpaired t test. (K) Basal ECAR of LLO56 and LLO118 T cells on D7 after in vivo activation by Listeria infection as described in (F). The values
represent the average of a minimum of three individual wells from individual mice from two independent experiments; p = 0.0065 by an unpaired t test. (L)
Maximal ECAR of LLO56 and LLO118 T cells on D7 after in vivo activation by Listeria infection as described in (G). The values represent the average of a
minimum of three individual wells from individual mice from two independent experiments; p = 0.0164 by an unpaired t test.
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FIGURE 2. Use of a second pair of low- and high-tonic signaling TCRtg CD4+ T cells, Marilyn and AND, respectively, further confirms that low-
tonic signaling correlates with increased basal metabolic activity.
(A) Mean CD5 levels are indicated for the four transgenic lines analyzed (LLO56, AND, LLO118, Marilyn), as well as a BL6 mouse (n = 2 mice each). (B)
Enriched CD4+ T cells from spleens of Marilyn and AND TCRtg mice were analyzed using a standard Seahorse protocol, as described in Fig. 1. A
representative OCR curve is shown. (C) Enriched CD4+ T cells from spleens of Marilyn and AND TCRtg mice were run using a standard Seahorse
protocol. A representative ECAR curve is shown. (D) Basal OCR, the first OCR data point collected, was plotted for Marilyn and AND (Continued)
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prepared using a NuGen Pico SL Kit, and 5.5 mg of cDNA was
hybridized to the microarrays using standard Affymetric proto-
cols. All data were normalized using RMA in Arraystar 12.
Microarray data have been deposited in the Gene Expression
Omnibus (https://www.ncbi.nlm.nih.gov/geo/) under accession
number GSE146069. Genes and metabolites analysis was per-
formed comparing the naive LLO118 and LLO56 T cells and D7 in
vivo–activated LLO118 and LLO56 T cells using Genes and
Metabolities (GAM) (https://artyomovlab.wustl.edu/shiny/gam/)
on an atom-based network (34, 35).
Bacterial infections
The L. monocytogenes strain 1043S used in this study was
generously provided by D. Portnoy (University of California,
Berkeley, CA), and L. monocytogenes infections of LLO56 and
LLO118 mice were performed as previously described (28).
Statistical analysis
Prism (versions 7 and 8) software for Mac OS X was used for all
statistical analysis. Statistical significance was determined using
either a paired t test (for Seahorse runs), an unpaired t test, or an
ANOVA test, and a p value,0.05 was designated as the criterion
for significance.
RESULTS
In naive mice, CD4+ T cells with lower tonic signaling have
higher rates of respiration and glycolysis than CD4+ T cells
with higher tonic signaling
To compare the basal metabolic profiles of LLO56 and LLO118,
splenocytes of naive, age-and sex-matched matched mice were
enriched for CD4+ T cells, and Seahorse platform analysis was
performed on the enriched populations. The respiratory rate of
LLO118 cells was higher than that of LLO56 cells, as evidenced by
the higher OCR of these cells (Fig. 1A). Specifically, baseline
respiration was higher in naive LLO118 CD4+ T cells than in naive
LLO56 cells, as wasmaximal respiration, reached after addition of
the uncoupling reagent FCCP (Fig. 1B, 1C). SRC, which has been
defined as a cell’s energy reserve capable of fueling cellular
function above and beyond basic energy needs, was also higher in
LLO118 than in LLO56 (36) (Fig. 1D). Likewise, glycolytic function
was greater in LLO118 than in LLO56, as evidenced by the higher
basal ECAR and the higher maximal ECAR of LLO118 cells (Fig.
1E–G). Interestingly, we found no difference in the ratio of OCR to
ECAR inLLO56andLLO118 cells, indicating that theyhave similar
relative reliance on respiration and glycolysis for meeting energy
needs (Fig. 1H). The same metabolic differences between LLO118
and LLO56were observedwhen the LLOT cells were activated in
vivowithListeria and harvested on d7 postinfection, duringwhich
LLO118TcellshadagreaterOCRandECARthanLLO56cells (Fig.
1I–L). Overall, these findings indicate that the less self-reactive
LLO118 CD4+ T cell is more metabolically active in its naive state
than the more self-reactive LLO56 cell.
To determine whether the inverse correlation between tonic
signaling and basal metabolismwas specific to the LLO system or
generalizable to other systems, we also interrogated the basal
metabolism of another set of CD4+ T cell transgenics, AND, and
Marilyn. AND recognizes Moth cytochrome C (MCC)/I-Ek (37),
whereasMarilyn recognizes the male Y Ag/I-Ab (38). Mandl et al.
(13) examined a panel of TCRtg lines, including ANDandMarilyn,
for their level of tonic signaling. Similar to LLO56, AND has high-
tonic signaling and thus expresses high levels of CD5; like LLO118,
Marilyn has lower tonic signaling and expresses lower levels of
CD5 (Fig. 2A).Mirroringourfindings in theLLOsystem, theCD5lo
Marilyn T cell had higher maximal respiration relative to AND
(Fig. 2B, 2E)andSRC(Fig. 2F); however, therewasnot a significant
difference in the basal metabolism (Fig. 2D). Maximal glycolytic
rates trended to be higher in Marilyn than in AND, but did not
reach a level of significance (Fig. 2C, 2H). The ratio of OCR to
ECAR in AND and Marilyn T cells did not reach a level of
significance, indicating that they have similar relative reliance on
respiration and glycolysis for meeting energy needs (Fig. 2I).
Collectively, these findings in the AND/Marilyn TCR systems
further supported our observation that cells with lower tonic
signaling have a higher metabolic capacity in their naive state.
Increased 2-NBD–glucose uptake correlates with the higher
basal metabolism in low-tonic signaling cells
Because we observed enhanced glycolysis in LLO118 compared
with LLO56, we also sought to determine if glucose uptake was
enhanced in these cells. To test this, wemeasured in vitro uptake of
2-NBDG, a nonmetabolizable glucose analogue, in LLO56 and
LLO118 T cells (39). Complementing our observation of higher
glycolysis inLLO118 cells, 2-NBDGuptakewas approximately twice
ashigh inLLO118cells as itwas inLLO56cells (Fig. 3A,3B). 2-NBDG
uptake was also measured in vivo following i.p. injection, and we
observed higher 2-NBDG uptake in LLO118 cells, relative to LLO56
cells (Fig. 3C). Similarly, 2NBDG uptake was also higher inMarilyn
cells relative to AND in vitro (Fig. 3D, 3E). We were further able to
pairs from individual Seahorse runs (n = 4). Plot points represent averages of a minimum of three wells; p = 0.0947 by a paired t test. (E) Maximal
OCR, the first OCR data point collected after the injection of FCCP, was plotted from Marilyn and AND pairs from individual Seahorse runs (n = 4).
Plot points represent averages of a minimum of three wells; p = 0.007 by a paired t test. (F) SRC was plotted from pairs of individual Seahorse runs.
SRC was calculated by subtracting the basal OCR from the maximal OCR. (G) Basal ECAR, the first ECAR data point collected, was plotted for Marilyn
and AND pairs from individual Seahorse runs (n = 4). Plot points represent averages of a minimum of three wells. (H) Maximal ECAR, the first ECAR
data point collected after the injection of FCCP, was plotted for Marilyn and AND pairs from individual Seahorse runs (n = 4). Plot points represent
averages of a minimum of three wells. (I) The ratio of OCR/ECAR was calculated by dividing the maximal OCR by the maximal ECAR for each pair
and the plot points represent averages of a minimum of three wells.
https://doi.org/10.4049/immunohorizons.2000055
490 CD4+ T CELL TONIC SIGNALING REGULATES BASAL METABOLISM ImmunoHorizons












FIGURE 3. 2-NBD–Glucose uptake analysis reveals metabolic differences between low- and high-tonic signaling CD4+ T cells can be extended
to the polyclonal population, and this difference emerges after initial TCR–self-pMHC interactions in the thymus.
(A) 2-NBDG uptake in naive splenocytes from either LLO56 (n = 3) or LLO118 (n = 4) mice was measured by FACS after a 20-min in vitro incubation.
Live/dead gating was used on single-cell suspensions, followed by doublet discrimination. Cells were then gated on the CD3+CD4+ population, and
a representative histogram is shown. (B) Quantified in vitro uptake is shown, and data are representative of three independent experiments. (C) In
vivo 2-NBDG uptake was measured by FACS 15 min after an IP injection of 2-NBDG in LLO56 (n = 4) and LLO118 (n = 4) mice. Live/dead gating was
used on single-cell suspensions, followed by doublet discrimination. Cells were then gated on the CD3+CD4+ population, and quantified uptake
is shown. Data are representative of three independent experiments. (D) 2-NBDG uptake in naive splenocytes from either AND (n = 3) or Marilyn
(n = 3) mice was measured by FACS after a 20-min in vitro incubation. Live/dead gating was used on single-cell suspensions, followed by doublet
discrimination. Cells were then gated on the CD3+CD4+ population, and a representative histogram is shown. (E) Quantified in vitro uptake is shown,
and data are representative of three independent experiments. (F) 2-NBDG uptake in naive splenocytes from a total of five individual C57BL/6J mice
in two separate experiments, was measured by FACS after a 20-min in vitro incubation. Live/dead gating was used on single-cell suspensions,
followed by doublet discrimination. Cells were then gated on the CD3+CD4+ population, and then further gated on CD5 expression (highest 10%
and lowest 10%). A representative is shown. (G) 2-NBDG uptake in naive splenocytes from a total of five individual C57BL/6J mice in two separate
experiments, was measured by FACS after a 20-min in vitro incubation. Live/dead gating was used on single-cell suspensions, followed by doublet
discrimination. Cells were then gated on the CD3+CD8+ population, and then further gated on CD5 expression (highest 10% and lowest 10%). A
representative is shown. (H) Quantified uptake is shown of 2-NBDG in polyclonal CD4+ (n = 5) and CD8+ (n = 5) T cells gated on (Continued)
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extend this finding into polyclonal T cells, in which we observed an
inverse correlation between CD5 levels and 2-NBDG uptake (Fig.
3F–H). In C57BL/6J mice, peripheral CD4+ T cells with the lowest
10% of CD5 expression in vitro took up significantly more 2-NBDG
thanperipheralCD4+Tcellswith thehighest 10%ofCD5expression
(Fig. 3F, 3H).A similardistinction in2-NBDGuptakebetweenCD5lo
and CD5hi was observed for CD8+ T cells (Fig. 3G, 3H). It should be
noted that the CD5lo and CD5hi populations are not completely
comprised of native cells, but normal mice from our mouse colony
have very low levels of activated T cells. Thus, the majority of the
T cells we examined were naive. These findings show an inverse
correlation between strength of TCR–self-pMHC interactions and
metabolism existed for both CD4+ and CD8+ T cells.
To determine if we could identify the divergence of glucose
uptake in the developmental timeline of LLO56 and LLO118, we
also examined different populations of thymocytes in vitro. We
found that indeveloping thymocytes,CD42CD82double-negative
(DN) thymocytes from LLO56 and LLO118 take up similar
amounts of 2-NBDG in vitro, as do CD4+CD8+ double-positive
(DP) thymocytes. However, starting in positively selected DP (in
this study, defined as CD4+CD8+ thymocytes expressing very high
levels ofTCRb andCD5) andCD4 single-positive, 2-NBDGuptake
in LLO56 decreases much more than the uptake of LLO118 (Fig.
3I). As this observed change coincided with the onset of positive
selection (and thereforeTCRsignaling), it supports our hypothesis
that increased self-pMHC–TCR interaction in a CD4+ T cell
predisposes that cell to lower basal metabolism.
Peripheral CD4+ T cells with increased sensitivity to
self-pMHC have decreased basal metabolism
To further elucidate the relationship between self-reactivity and
metabolism in polyclonal CD4+ T cells, we sought a method that
would allow us to genetically control metabolism. To this end, we
employed a knock-in mouse line with inducible expression of
Scn5a (sodium channel protein type five subunit a) (28). Scn5a is
the pore-forming component of a voltage-gated sodium channel
typically expressed in cardiac myocytes. We previously reported
that when Scn5a is ectopically expressed in DP thymocytes, they
are endowedwith enhanced signaling to weak self-pMHC ligands
during positive selection. Scn5a expression in CD4+ T cell hybrids
equips them with increased sensitivity to self-pMHC, to the level
that they are capable of responding to their positive-selecting
peptide (40). Recently, we demonstrated that expression of Scn5a
in peripheral CD4+ T cells (using Scn5a+CD42Cre+ mice) resulted
in increased proximal TCR signaling and increased peripheral
CD5 expression and this expression of Scn5a in the LLO118
T cells led to an impaired in vivo response to L. monocytogenes
CD5hi and CD5lo populations. (I) in vitro 2-NBDG uptake in naive thymocytes from either LLO56 (n = 4) or LLO118 (n = 4) mice was measured by
FACS after a 20-min incubation. Live/dead gating was used on single-cell suspensions, followed by doublet discrimination. Cells were then gated
based on CD4 and CD8 expression into DP (CD4+CD8+), DN (CD42CD82), and single-positive (SP; CD4+CD82) populations. Within the DP
population, another gate was drawn on TCRb++/CD5++ cells to interrogate DP cells initiating the process of positive selection. The 2-NBDG uptake
of each population is shown, and data are representative of three independent experiments.
FIGURE 4. Increasing TCR signaling results in correspondingly lower
respiration and glycolysis rates in naive CD4+ T cells.
(A) Enriched CD4+ T cells from spleens of Scn5+CD42cre+ mice and
Scn5+CD42cre2 mice were analyzed using a standard Seahorse pro-
tocol as described in Fig. 1. Shown is the OCR of three combined ex-
periments, with the points representing the mean 6 SEM. The p values
are shown for the basal (time 09) and maximal (time 429) values. (B)
Enriched CD4+ T cells from spleens of from Scn5+CD42cre+ mice and
Scn5+CD42cre2 paired mice were run using a standard Seahorse
protocol as described in Fig. 1. Shown is the ECAR of three combined
experiments, with the points representing the mean 6 SEM. The p
values are shown for the basal (time 09) and maximal (time 429) values.
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infection (28). To directly test the impact of increased sensitivity
to self-pMHConmetabolism,weusedSeahorse platform analysis
to compare Scn5a+CD42Cre+mice to Scn5a+CD42Cre–negative
littermates. Mirroring the differences we observed in LLO56
and LLO118 basal metabolism, we found that increasing self-
sensitivity in Scn5a+CD42Cre+ mice led to a compensatory
decrease in basal respiration (Fig. 4A), maximal respiration (Fig.
4A), and basal ECAR (Fig. 4B) and maximal ECAR (Fig. 4B).
These data indicate that increasing TCR signaling sensitivity
in naive CD4+ T cells results in a compensatory decrease in
metabolism.
Identification of metabolic pathway differences between the
LLO T cells in their activated states
To gain unbiased insight into differences between LLO118 and
LLO56 CD4+ T cells, we performed transcriptional profiling of
naive LLO118 and LLO56 T cells and those isolated at D7
postinfection. The naive cells had few transcriptional differences,
withnoobvious candidates to explain their distinct characteristics.
We thenanalyzedtheD7data in thecontext ofmetabolicnetworks
by using GAM analysis (34). Using this innovative approach, we
found coordinated changes in a number of metabolic pathways
(Fig. 5). Overall, LLO118 cells appeared to be metabolically much
more active than LLO56 cells, consistent with our Seahorse
analysis (Fig. 1). We found a metabolic bifurcation point that
discriminated between LLO118-like metabolism and LLO56-like
metabolism, centered at glycerol 3-phosphate (Fig. 5, inset). In
LLO118T cells, thismetabolite can be directed toward the glycerol
phosphate shuttle via the action of mitochondrial glycerol phos-
phate dehydrogenase (mGpd2). In LLO56 T cells, glycerol
3-phosphate is directed toward glycerolipid metabolism via the
enzyme glycerophosphocholine phosphodiesterase 1 (Gpcpd1).
The glycerol phosphate shuttle is a secondary mechanism that
allowsNADHgenerated in the cytosol byglycolysis to contribute
to OXPHOS in the mitochondria, and thereby sustain ATP
production (reviewed in Ref. 41). The rate-limiting enzyme for
the glycerol phosphate shuttle is mGPD2. mGPD2 is a mito-
chondrial flavin-linked respiratory chain dehydrogenase that
oxidizes glycerol-3-phosphate to dihydroxyacetone phosphate
with concurrent reduction of FAD to FADH2 and transfer of
electrons to CoQ (Fig. 5 inset) (41). Recently, the glycerol
phosphate shuttle has been shown to regulate macrophage
inflammatory responses (42) and promote skeletal muscle
regeneration (43), supporting the concept that it could be
involved in the observed metabolic differences between
LLO118 and LLO56 T cells.
FIGURE 5. Metabolic pathway differences between LLO118 and LLO56 and identification of mGPD2 as a candidate gene.
Microarray data for LLO118 and LLO56 T cells activated in vivo by L. monocytogenes infection were analyzed on D7 post infection for metabolic
pathway differences using the GAM program, revealing significant differences between the two T cells. The pathways upregulated in LLO118 are
shown in blue, and those in LLO56 shown in red, with the intensity of the lines corresponding to the level of transcription. The enzymes involved in
each step of the pathways are shown. For clarity, the substrates and products have been omitted. The inset highlights a key branch point between
LLO118 and LLO56 T cells, highlighting mGPD2 as a candidate gene involved for the observed metabolic differences.
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FIGURE 6. Inhibition of the glycerol phosphate shuttle reduces the metabolism of LLO118 cells.
(A) Metabolic analysis using the Seahorse platform was performed on LLO118 and LLO56 T cells. The specific inhibitor of glycerol 3 phosphate
dehydrogenase (iGP-1, dissolved in DMSO), a key enzyme in the glycerol phosphate shuttle, was added at a final concentration of either 2.5 or 5 mM.
A representative OCR curve is shown (n = 3). (B) Maximum OCR of LLO118 T cells from three individual experiments treated with iGP-1. The values
represent individual wells with the mean value shown. The data from (A) are included in this graph. An unpaired t test was performed for each
individual experiment. (C) Maximum ECAR of LLO118 T cells from three individual experiments treated with iGP-1. The values represent individual
wells with the mean value shown. An unpaired t test was performed for each individual experiment. (D) Maximum OCR of LLO56 T cells from three
individual experiments treated with iGP-1. The values represent individual wells with the mean value shown. The data from (A) are included in this
graph. An unpaired t test was performed for each individual experiment. (E) Maximum ECAR of LLO56 T cells from three individual experiments
treated with iGP-1. The values represent individual wells with the mean value shown. An unpaired t test was performed for each individual
experiment.
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Enhanced glycerol phosphate shuttle function contributes
to basal metabolism of LLO118
To obtain evidence in support of the glycerol phosphate shuttle in
the enhanced metabolism of LLO118 T cells, we targeted the
mGpd2 enzyme, using an available specific inhibitor, iGP-1 (44).
iGP-1 specifically inhibits the enzymatic activity of mitochondrial
GPD2 (mGPD2), but not the cytosolic GPD2 isoform (44). iGP-1 is
cell permeable but not bioavailable in vivo. Treatment of the
LLO118 T cells in vitro with the iGP-1 significantly reduced their
metabolic OCR and ECAR (Fig. 6A–C). Treatment of the LLO56
T cells with iGP-1 had a significant but weaker effect on their
metabolism (Fig. 6A, 6D, 6E). This finding provides support for
the involvement of the glycerol phosphate shuttle in the increased
metabolism of the LLO118 T cells.
DISCUSSION
Interactions between a T cell through its TCR and self-pMHC on
APCs are critical for the development and maintenance of an
adaptive immune system. The role of self-pMHC in positive
selection of T cells in the thymus is well established (reviewed in
Ref. 45). TCR–self-pMHC interactions in the periphery are
important for survival of T cells and initiation of activation. In
this present study, we extended the role of these self-pMHC
complexes to being involved in setting the basal metabolism of
naiveT cells. In a polyclonal T cell repertoire, there is a continuum
of strengths of interactions with self-pMHC, and we have shown
that there is an inverse relationship between the strength of these
interactions and basal metabolism. Thus, T cells with the weaker
interactions have a higher basal metabolism, and conversely those
with stronger interactions have lower basal metabolisms. We
propose that the reason for this tuning of the basal metabolism is
that it represents a homeostatic balance between activation and
autoimmunity, and permits the full T cell repertoire to participate
in immune responses. There is emerging evidence that there are
functional differences in CD4+ T cells with different strengths of
self-pMHC reactivity, whichwould support the notion that tuning
of self-reactivity, metabolism, and T cell function allows the full
repertoire to be involved in some aspect of an immune response
(12, 13, 28, 29, 46). Other factors besides the level of self-reactivity
of T cells can also be involve in regulating metabolism, such as the
level of cytokine receptors. Anergic self-reactive T cells and
T regulatory cells have been shown to have altered metabolism
comparted to naive cells (47), but the development of both of these
populations is still influenced by the strength of the TCR–self-
pMHC interactions.
Through the analysis of transcriptional data by the GAM
program (34), we identified the glycerol phosphate shuttle as
onepotential keymetabolic pathwaydifference betweenT cells
with high and low basal metabolisms. Thus, cells with higher
basal metabolism require an increased glycerol phosphate
shuttle function to provide NADH generated in the cytosol by
glycolysis to contribute to OXPHOS in the mitochondria.
Flavell and colleagues (48) have recently shown that themalate
aspartate shuttle, another mechanism through which cyto-
plasmic NADH is shuttled to the mitochondria, was important
in T cell differentiation. The malate aspartate shuttle was
necessary for the proliferation of Th cells, whereas, succinate
dehydrogenase subsequently antagonized differentiation and
enforced terminal effector function. We have identified the
enzyme mitochondrial glycerol phosphate dehydrogenase
(mGPD2) as a potential key enzyme in the enhanced metab-
olism of T cells withweak self-pMHC interactions. mGPD2 has
been recently shown by Horng and colleagues (42) to be a key
regulator of glucose-oxidation in LPS-stimulatedmacrophages
in the optimal control of inflammatory gene induction and
suppression.
In these studies, we provide evidence of an inverse correlation
between the level of self-reactivity and the metabolism of a T cell.
There are some limitations from our experiments. It is currently
very difficult to enhance tonic signaling in T cells. We have
developed the Scn5a+model system, which does show an increase
in the tonic signaling.Westill donotknowhowtheScn5a+voltage-
gated sodium channel is enhancing tonic signaling, and how it
relates to the pathways normally involved in tonic signaling. We
found increased uptake of the glucose analogue 2-NBD–glucose in
cells with low-tonic signaling. Future studies of glucose
metabolism in naive CD4+ T cells is difficult with current
techniques because naive T cells have a low uptake of labeled
compounds needed to trace metabolic pathways and products
(49). A recent promising report using a pulsed stable isotope
labeling by amino acids in cell culture approach, showed that
naive T cells have a large number of stalled ribosomes, which
can rapidly respond upon T cell activation (50). They did not
examine if naive T cells with high- and low-tonic signaling had
differences in the number of stalled ribosomes in this initial
report. The implication ofmGPD2 in the enhancedmetabolism
between the LLO56 and LLO118 cells was based on the GAM
analysis and use of the iGP-1 inhibitor. Many in vitro metabolic
inhibitors have shown off-target effects. Clearly definitive
genetic studies will have to be performed to establish the role
of this pathway in basal metabolism, with the caveat of
redundant metabolic pathways complicating the interpreta-
tion. Because mGPD2 is expressed in multiple immune cell
types, a conditional knockout allele and a T cell–specific cre-
deletermouse should address this issue. Another area of future
investigation will be to establish how signaling through the
TCR via self-pMHC controls basal metabolism. Roose and
colleagues (46) have made the important finding that tonic
mTORC1 signals in naive CD4+ T cells influence T cell fate
decisions and that theRas exchange factorRasgrp1 is necessary to
generate tonic mTORC1 signals. The well-established involve-
ment of TORC1 in controlling cellularmetabolism thus provides a
potential mechanism by which the strength of TCR–self-pMHC
interactions inversely regulate basal metabolism. Overall, our
findings reveal an inverse relationship between the strength of
tonic signaling in naive CD4+ T cells and their basal metabolism,
with important implications for T cell activation, differentiation,
and function.
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